Alder BioPharmaceuticals (NASDAQ:ALDR) announced data from the proof-of-concept clinical trial of ALD403 published in the October 6, 2014 issue of Lancet Neurology demonstrates that ALD403 met the primary study endpoint and is effective for the preventative treatment of migraine. ALD403 is Alder’s lead clinical candidate targeting the calcitonin gene-related peptide, or CGRP, for migraine prevention. CGRP is a small protein that is critically important in the transmission of and heightened sensitivity to pain experienced in migraine. Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) belongs to Healthcare sector. Its weekly performance is -8.91%. On last trading day company shares ended up $11.55. Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) distance from 50-day simple moving average (SMA50) is -19.88%.
CalAmp Corp. (NASDAQ:CAMP) reported Q2 earnings on Tuesday. Shares of the company were up 21 percent. Looking at our second quarter results in more detail, consolidated revenue was $59.2 million, up slightly year-over-year. Wireless Datacom revenue up 6% to $50.2 million, an all-time record for a single quarter. Satellite revenue in the quarter was $9 million, down 22% year-over-year. At the bottom line, we achieved GAAP basis earnings of $0.09 per diluted share in the second quarter with non-GAAP earnings of $0.21 per diluted share. Strong cash flow from operating activities of $8.5 million helped to push our cash, cash equivalents, and marketable securities balance to $36.8 million with zero bank debt. In our Wireless Networks business, energy revenues rebounded sharply in the second quarter, primarily due to our solar power OEM customer. Based on commitments received from Caterpillar, we now expect revenue from this customer during the second half of our current fiscal year will exceed $10 million. CalAmp Corp. (NASDAQ:CAMP) shares advanced 21.03% in last trading session and ended the day at $19.97. CAMP Gross Margin is 33.80% and its return on assets is 7.40%. CalAmp Corp. (NASDAQ:CAMP) quarterly performance is 9.67%.
Phillips 66 (NYSE:PSX) shut the No. 40 FCC at the 146,000 b/d Borger refinery for a month-long maintenance period, while Petrobras shut its 106,000 b/d Pasadena refinery, which includes a 56,000 b/d FCC. On 07 October, Phillips 66 (NYSE:PSX) shares remains unchanged and was closed at $77.35. PSX EPS growth in last 5 year was 11.10%. Phillips 66 (NYSE:PSX) year to date (YTD) performance is 1.43%.
Heico Corp (NYSE:HEI) last released its earnings data on Tuesday, August 26th. The company reported $0.49 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.44 by $0.05. The company had revenue of $291.00 million for the quarter, compared to the consensus estimate of $296.43 million. During the same quarter in the prior year, the company posted $0.43 earnings per share. The company’s quarterly revenue was up 8.9% on a year-over-year basis. Analysts expect that Heico Corp will post $1.77 EPS for the current fiscal year. HEICO Corporation (NYSE:HEI) ended the last trading day at $46.49. Company weekly volatility is calculated as 2.01% and price to cash ratio as 134.26. HEICO Corporation (NYSE:HEI) showed a weekly performance of -0.45%.
The BlackBerry Ltd (NASDAQ:BBRY) Passport is an oddly-shaped smartphone running the Canadian manufacturer’s latest mobile software, BB10.3. It also comes with a blast from the past: a physical QWERTY keyboard designed to recall the company’s storied history of selling the best portable email machines, while simultaneously erasing memories of the lackluster touch-centric BlackBerry Z10 and Z30 from last year. BlackBerry Ltd (NASDAQ:BBRY) belongs to Technology sector. Its net profit margin is -6.73% and weekly performance is -7.14%. On last trading day company shares ended up $9.23. BlackBerry Ltd (NASDAQ:BBRY) distance from 50-day simple moving average (SMA50) is -8.06%.